Life-threatening hemophagocytic syndrome triggered by disseminated toxoplasmosis in a young patient with previously unknown AIDS.
Acquired Immunodeficiency Syndrome
Critical care
Immunocompromised Host
Lymphohistiocytosis, Hemophagocytic
Toxoplasmosis
Journal
La Revue de medecine interne
ISSN: 1768-3122
Titre abrégé: Rev Med Interne
Pays: France
ID NLM: 8101383
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
03
03
2022
revised:
19
07
2022
accepted:
27
07
2022
pubmed:
12
9
2022
medline:
7
10
2022
entrez:
11
9
2022
Statut:
ppublish
Résumé
Hemophagocytic syndrome is a rare life-threatening disorder that can be triggered by various conditions such as HIV infection and opportunistic agents. We report a case of disseminated toxoplasmosis complicated with severe hemophagocytic syndrome and revealing an unknown acquired immunodeficiency syndrome. The patient presented with multiple organ failure in intensive care unit. Once diagnosed, he benefitted from etoposide infusion, administration of specific anti-toxoplasmosis treatments and secondary antiretroviral therapy. He was alive at intensive care unit discharge and returned home with little sequalae. This case illustrates both the importance of rapid investigations of hemophagocytic syndrome etiologies in HIV positive patients and the necessity to prompt etoposide and specific treatments in order to improve potentially dramatic outcomes.
Identifiants
pubmed: 36089427
pii: S0248-8663(22)00603-8
doi: 10.1016/j.revmed.2022.07.016
pii:
doi:
Substances chimiques
Etoposide
6PLQ3CP4P3
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
622-625Informations de copyright
Copyright © 2022 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.